Illumina | ILMN - Ebit

Aktienkurs
121.83
Täglich Wechseln
2.55 2.14%
Monatlich
1.45%
Jährlich
43.06%
Q1 Prognose
115.35




Ebit Veränderung Datum
Agilent USD 353M 90M 2025-12
Bio Techne USD 54.46M 6.8M 2025-12
Bio-Rad Laboratories USD -418.8M 845.4M 2025-09
Boston Scientific USD 1.24B 203M 2025-12
Bruker USD 76.3M 7.6M 2025-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Danaher USD 1.5B 348M 2025-12
Dentsply International USD 538M 26M 2025-12
Edwards Lifesciences USD 370.3M 54.8M 2025-12
Exact Sciences USD -25M 22.85M 2025-09
Hologic USD 240.9M 12.1M 2025-12
Illumina USD 256M 6M 2025-12
Intuitive Surgical USD 865.3M 97.5M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Laboratory Of America USD 382M 11M 2025-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Myriad Genetics USD -5.5M 11.1M 2025-03
OraSure Technologies USD -13.59M 2.13M 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Quest Diagnostics USD 386M 0 2025-12
Quidel USD -37.3M 82.5M 2025-12
Repligen USD 19.97M 3.16M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Standard Biotools USD -32.89M 14.62M 2025-09
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Waters USD 270.52M 78.4M 2025-12